Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Protzer

Showing results (121-130 of 308) with videos related to

Pageof 31
Sort By:
Vaccines|February 28, 2023
Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in MiceAnn-Sophie Stephan, Anna D Kosinska, Martin Mück-Häusl, et al.
Antiviral Therapy|January 7, 2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudineAndreas Geipel, Pia L Seiz, Hauke Niekamp, et al.
JHEP Reports : Innovation in Hepatology|October 23, 2025
NTCP ubiquitination enables HBV infectionMonique D Appelman, Thuc-Anh Nguyen, Andreas Oswald, et al.
Journal of Medical Virology|January 21, 2010
Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletesDieter Hoffmann, Bernd Wolfarth, Hubert G Hörterer, et al.
Vaccine|January 12, 2013
A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic micePascale Buchmann, Claudia Dembek, Larissa Kuklick, et al.
Gut|February 10, 2015
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGiuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, et al.
JHEP Reports : Innovation in Hepatology|July 28, 2022
Mitosis of hepatitis B virus-infected cells <i>in vitro</i> results in uninfected daughter cellsThomas Tu, Benno Zehnder, Jochen M Wettengel, et al.
Molecular Therapy. Methods & Clinical Development|December 2, 2021
Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptorsSophia Schreiber, Melanie Honz, Weeda Mamozai, et al.
JHEP Reports : Innovation in Hepatology|June 30, 2026
Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacyThomas Michler, Anna Kosinska, Osman Merdan, et al.
The Journal of Infectious Diseases|September 8, 2016
Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory ResponseOrlando Mayorga, Silja Bühler, Veronika K Jaeger, et al.
Pageof 31

Showing results (121-130 of 308) with videos related to

Sort By:
Pageof 31
Vaccines|February 28, 2023
Evaluation of the Effect of CD70 Co-Expression on CD8 T Cell Response in Protein-Prime MVA-Boost Vaccination in MiceAnn-Sophie Stephan, Anna D Kosinska, Martin Mück-Häusl, et al.
Antiviral Therapy|January 7, 2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudineAndreas Geipel, Pia L Seiz, Hauke Niekamp, et al.
JHEP Reports : Innovation in Hepatology|October 23, 2025
NTCP ubiquitination enables HBV infectionMonique D Appelman, Thuc-Anh Nguyen, Andreas Oswald, et al.
Journal of Medical Virology|January 21, 2010
Elevated Epstein-Barr virus loads and lower antibody titers in competitive athletesDieter Hoffmann, Bernd Wolfarth, Hubert G Hörterer, et al.
Vaccine|January 12, 2013
A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic micePascale Buchmann, Claudia Dembek, Larissa Kuklick, et al.
Gut|February 10, 2015
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoproteinGiuseppe A Sautto, Karin Wisskirchen, Nicola Clementi, et al.
JHEP Reports : Innovation in Hepatology|July 28, 2022
Mitosis of hepatitis B virus-infected cells <i>in vitro</i> results in uninfected daughter cellsThomas Tu, Benno Zehnder, Jochen M Wettengel, et al.
Molecular Therapy. Methods & Clinical Development|December 2, 2021
Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptorsSophia Schreiber, Melanie Honz, Weeda Mamozai, et al.
JHEP Reports : Innovation in Hepatology|June 30, 2026
Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacyThomas Michler, Anna Kosinska, Osman Merdan, et al.
The Journal of Infectious Diseases|September 8, 2016
Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory ResponseOrlando Mayorga, Silja Bühler, Veronika K Jaeger, et al.
Pageof 31